Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. Daniel Pollyea

Leukemia · CU Anschutz Medical Campus

View

Dr. Shella Saint Fleur-Lominy

Leukemia · UMSOM

View

Dr. Azra Raza

Leukemia · CUIMC

View

Dr. Molly Imgruet

Leukemia · Stanford

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JADr. Jessica Altman
    Leading Voice

    Dr. Jessica Altman

    Hematology & Oncology · Leukemia
    Northwestern Medicine
    jessicaa

    Research

    FLT3 as a germ line driver in AML: expanding the landscape of leukemia predisposition

    2026

    Via Blood Neoplasia

    Research

    Mutant p53 promotes clonal hematopoiesis by generating a chronic inflammatory microenvironment

    2026

    Via Journal of Clinical Investigation

    Research

    Outcomes of relapsed or refractory acute myeloid leukemia after menin inhibition failure

    2026

    Via Blood Advances

    Research

    Donor-derived acute myeloid leukemia after solid organ transplant: evidence for leukemic stem cell transmission

    2026

    Via Leukemia & Lymphoma

    Research

    Validation of the Body Compassion Scale in multiple sclerosis

    2026

    Via Rehabilitation Psychology

    Research

    Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial

    2026

    Via Blood Neoplasia

    Research

    Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia

    2026

    Via Haematologica

    Research

    QuANTUM-Wild: a Phase III, randomized trial of quizartinib in newly diagnosed FLT3-ITD-negative acute myeloid leukemia

    2026

    Via Future Oncology

    Research

    PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells

    2026

    Via Blood Advances

    Research

    Dynamic genetic and nongenetic RAS-pathway activation drives resistance to FLT3 and BCL2 inhibitor therapy

    2026

    Via Blood

    Research

    Beyond mindfulness: the importance of body compassion in colorectal cancer distress

    2025

    Via Frontiers in Psychology

    Research

    Academic Community Partnership in Acute Promyelocytic Leukemia and Early Mortality: The ECOG-ACRIN EA9131 Trial.

    2025

    Via JAMA oncology

    Research

    Clinicopathologic Characteristics and Prognostic Profile of Chronic Myeloid Neoplasms With Somatic NF1 Mutations in Adult Patients.

    2025

    Via European journal of haematology

    Research

    Targeting scavenger receptor class B type 1 with a bioinspired ligand induces apoptosis or ferroptosis in AML.

    2025

    Via Blood neoplasia

    Research

    Ziftomenib in Relapsed or Refractory-Mutated AML.

    2025

    Via Journal of clinical oncology